Publications by authors named "Steven Francom"

Claim this Profile
S
Systemic Safety in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration: A Patient-Level Pooled Analysis.
Marco A Zarbin, Steven Francom, Susanna Grzeschik, Lisa Tuomi, Zdenka Haskova

Ophthalmol Retina· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Systemic Safety of Ranibizumab in Patients 85 Years and Older with Neovascular Age-Related Macular Degeneration.
Pravin U Dugel, Natasha Singh, Steven Francom, Ronald A Cantrell, Susanna M Grzeschik

Ophthalmol Retina· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular Safety of Ranibizumab in Patients With Diabetic Macular Edema: A Pooled Analysis of Patient-Level Data From Randomized Clinical Trials.
Marco A Zarbin, Cornelia Dunger-Baldauf, Zdenka Haskova, Prashil Koovejee, Marie-Catherine Mousseau, Steven Francom

JAMA Ophthalmol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials.
Neil M Bressler, David S Boyer, David F Williams, Steven Butler, Steven F Francom

Retina· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial.
William Stohl, Juan Gomez-Reino, Ewa Olech, Jean Dudler, Roy M Fleischmann, Steven Francom

Ann Rheum Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects.
Nenad Sarapa, Ihor Gussak, Branislav Vajdic, Samuel George, Ljupco Hadzievski, Steven F Francom

J Electrocardiol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration.
David S Boyer, Jeffrey S Heier, David M Brown, Steven F Francom, Tsontcho Ianchulev

Ophthalmology· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of clinically significant QTc prolongation in phase I studies in healthy participants: comparison of 2 semiautomated QT measurement methods.
Nenad Sarapa, Steven F Francom, Sara M Azzam, Prachi K Wickremasingha, Benoit Tyl

J Clin Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies.
Nkechi E Azie, Gregory Adams, Borje Darpo, Steven F Francom, Emery C Polasek

Ann Noninvasive Electrocardiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers.
Carlos A Rodríguez, Nkechi E Azie, Gregory Adams, Kirsteen Donaldson, Steven F Francom

J Clin Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.
Nenad Sarapa, Joel Morganroth, Jean-Philippe Couderc, Steven F Francom, Borje Darpo

Ann Noninvasive Electrocardiol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics of linezolid are not affected by concomitant intake of the antioxidant vitamins C and E.
Toufigh Gordi, Lai Hock Tan, Catherine Hong, Nancy J Hopkins, Steven F Francom

J Clin Pharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valdecoxib, a COX-2-specific inhibitor, does not affect cardiac repolarization.
Nenad Sarapa, Margaret R Britto, Barbara Cotton, Steven R Cox, Steven F Francom

J Clin Pharmacol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam.
Daniel L Wolf, Paul J Desjardins, Peter M Black, Steven R Francom, Ramon W Mohanlal

J Clin Psychopharmacol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular effect of almotriptan in treated hypertensive patients.
Joseph C Fleishaker, Janet D McEnroe, Nkechi E Azie, Steven F Francom, Barbara J Carel

Clin Pharmacol Ther· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis